Hudson Robotics, Inc. introduced the VaryScreen ADME-Tox integrated workstation for profiling of the absorption, distribution, metabolism, and excretion (ADME) properties of drug molecules. VaryScreen ADME-Tox enables researchers to perform screens starting with just a single plate, yielding a complete profile more quickly and at a lower cost.
The basic VaryScreen ADME system contains everything needed to support biochemical assays that measure the physicochemical properties of a drug molecule (solubility, lipophilicity, pKa, protein binding). It supports PAMPA and CACO 2 permeability assays and can measure a drug’s affinity toward such key toxilogical targets as hERG and various CYP metabolic enzymes.
Controlled by Hudson Robotics’s SoftLinx scheduling software, VaryScreen ADME-Tox comes with sample protocols for each of the included ADME/Toxicity methods. The protocols are easily modified to meet user requirements, and more assays can be added to further customize follow-up screening efforts. VaryScreen ADME-Tox includes a multi-mode reader that not only supports the wide range of protocols, but also runs primary and secondary screens. This enables ADME/Tox profiling to be carried out automatically on hits found in the assays.
Filed Under: Drug Discovery
